Brad Finstad (R-MN)
To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.
A Republican bill with 7 Republican cosponsors · See all 7 cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill aims to prohibit the use of Federal funds for certain Food and Drug Administration activities. Specifically, it stops money from being used to implement, administer, or enforce a final rule regarding "Medical Devices; Laboratory Developed Tests." This rule was submitted for publication in the Federal Register on May 6, 2024. The bill also applies to any rule that is substantially similar to that one.
Yes
- Scored +3
Would business owners be better off under this?
The bill benefits diagnostic laboratories and medical device companies by preventing the enforcement of new regulatory requirements for laboratory developed tests.
The opposite
- Scored -2
Does this give the federal government more power?
The bill limits the regulatory power of a federal agency by prohibiting the use of funds to enforce a specific rule.
- Scored -2
Does this make health care easier to get in general?
The bill may hinder healthcare access by preventing the regulation and oversight of laboratory developed tests.
- Scored -1
Does this reduce what the federal government spends?
The bill reduces government spending by prohibiting the use of Federal funds for the enforcement of the specified FDA rule.
Who it would affect, and how
Potential Positive Impacts for People
- Prevention of Rule Enforcement: By prohibiting Federal funds, the bill stops the implementation, administration, or enforcement of the final rule relating to "Medicals Devices; Laboratory Developed Tests" (Section 1).
Potential Negative Impacts for People
- Restriction of FDA Rule Implementation: The bill prevents the use of Federal funds to implement, administer, or enforce the specific Food and Drug Administration final rule submitted on May 6, 2024, or any substantially similar rule (Section 1).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would business owners be better off under this? — The bill benefits diagnostic laboratories and medical device companies by preventing the enforcement of new regulatory requirements for laboratory developed tests.
- Governance And Ideology
- Does this give the federal government more power? — The bill limits the regulatory power of a federal agency by prohibiting the use of funds to enforce a specific rule.
- Healthcare
- Does this make health care easier to get in general? — The bill may hinder healthcare access by preventing the regulation and oversight of laboratory developed tests.
- Economy And Finance
- Does this reduce what the federal government spends? — The bill reduces government spending by prohibiting the use of Federal funds for the enforcement of the specified FDA rule.
- 8/8/2025
- 1 Cosponsor added.
- 4/1/2025
- 1 Cosponsor added.
- 3/21/2025
- 1 Cosponsor added.
- 3/4/2025
- 1 Cosponsor added.
- 2/27/2025
- 1 Cosponsor added.
- 2/24/2025
- 1 Cosponsor added.
- 2/21/2025
- Referred to the House Committee on Energy and Commerce.
- 1 Cosponsor added.
- Introduced in House
Andy BarrRepublican · Kentucky
Dan CrenshawRepublican · Texas
Neal DunnRepublican · Florida
Craig GoldmanRepublican · Texas
Mariannette Miller-MeeksRepublican · Iowa
August PflugerRepublican · Texas
Randy WeberRepublican · Texas